SCHEMBL8296603

SCHEMBL8296603

Cc1cccc(C(=O)O)c1OCCOC1CCCCO1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
KDM4C Q9H3R0 1/20 0.40
GAA P10253 1/20 0.38
F2 P00734 1/20 0.38
F9 P00740 1/20 0.38
F10 P00742 1/20 0.38
PLAU P00749 1/20 0.38
PLAT P00750 1/20 0.38
F11 P03951 1/20 0.38
KLKB1 P03952 1/20 0.38
F7 P08709 1/20 0.38
CREBBP Q92793 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
EP300 Q09472 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8299866 0.89 MEN1 (0.47) MEN1KMT2AALDH1A1KDM4EKDM4C
SCHEMBL8297698 0.89 MEN1 (0.47) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL8296596 0.86 MEN1 (0.51) MEN1KMT2AKDM4CCREBBPNPC1
SCHEMBL8302809 0.86 KMT2A (0.51) MEN1KMT2AKDM4CGAAF2
SCHEMBL18095222 0.82 MEN1 (0.47) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL871773 0.81 KMT2A (0.55) MEN1KMT2AALDH1A1KDM4EKDM4C
SCHEMBL16036295 0.80 MEN1 (0.49) MEN1KMT2AALDH1A1KDM4CCREBBP
SCHEMBL21818634 0.80 KMT2A (0.51) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL17238830 0.79 MEN1 (0.46) MEN1KMT2AALDH1A1KDM4CCREBBP
SCHEMBL6769242 0.78 CXCR2 (0.50) ALDH1A1KDM4EHPGDHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090035313-A1 Compounds PFIZER INC. 2009-02-05 US disclosed
EP-1651641-B1 NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS PFIZER LTD (GB) 2007-05-23 EP disclosed
WO-2005009965-A1 NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS PFIZER LIMITED (GB) 2005-02-03 WO disclosed
WO-2005009995-A1 NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS PFIZER LIMITED (GB) 2005-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090035313-A1 Compounds NQO1, NAMPT, NNT MEN1 532/4885KMT2A 2721/4885ALDH1A1 212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.